One mouse that received the 18a LNA treatment did not have appreciable tumor burden at euthanization (i.e., not enough tissue for downstream analysis) and so was not included in further analyses
Whilst the US Food and Drug Administration (FDA) has approved five drug therapies to treat obesity (orlistat, phentermine/topiramate, lorcaserin, naltrexone/bupropion, liraglutide), the European Medicines Agency (EMA) has approved only three drug therapies (orlistat, bupropion/naltrexone and liraglutide) [8] at the time of writing
Please be careful about choosing healthy foods to see results
We know how to review your medical timeline, connect the dots, and hold large companies accountable
In plain terms: it can help a little, especially alongside diet and exercise, but it is not a stand-alone weight-loss solution